Seboquiro, Erline Jhyl M.

HRN: 22-23-54  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
CEFUROXIME 500MG (TAB)
11/21/2022
11/28/2022
PO
500mg
Q12
S/P NSD; UTI
Waiting Final Action 
11/21/2022
METRONIDAZOLE 500MG (TAB)
11/21/2022
11/28/2022
PO
500mg
Q8
S/P NSD; Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: